Securities America, plaintiffs making 'substantial progress'

Securities America, plaintiffs making 'substantial progress'
In an e-mail sent to brokers Friday evening, Securities America said crucial negotiations with investors suing the B-D could lead to a final resolution of the dispute. Without such an agreement, the brokerage -- and its 1,800 reps -- may be facing the end of the line.
MAY 23, 2011
By  Bloomberg
After canceling a conference call with brokers on Friday afternoon, Securities America Inc. told its brokers that its negotiations with lawyers representing clients who bought $400 million were moving forward. “We made substantial progress in our mediation and all interested parties have committed to a process that we hope will result in a full and final resolution of these matters,” wrote Janine Wertheim, a spokeswoman, in an e-mail. The firm sent a similar e-mail to its brokers at about 7:00 on Friday evening The firm, along with its parent, Amerprise Financial Inc., is trying to resolve a class action lawsuit and numerous arbitration claims in connection with the sale of $400 million of allegedly fraudulent private placements. Securities America advisers spent a tense week as the firm faced the potential threat of shutting down due to legal expenses and damages from litigation — if some sort of wide- ranging settlement is not reached. On March 18, its chief financial officer Kelly Windorski testified in federal court in Dallas that the firm could go out of business if a federal judge rejected Securities America's initial, proposed $21 million settlement with investors. Judge W. Royal Furgeson Jr. rejected that proposed settlement and later sent the two sides into mediation. That process started Thursday in Chicago. The mediation is being overseen by retired federal judge James M. Rosenbaum. The multi-million dollar legal dilemma at Securities America has been unfolding since July 2009, when the Securities and Exchange Commission charged two sponsors of high risk private placements with fraud. Those sponsors, Medical Capital Holdings Inc. and Provident Royalties LLC, sold about $2.7 billion of investments through dozens of independent broker-dealers, many of which have gone out of business due to crushing legal bills and liabilities. Securities America brokers were by far the biggest seller of Medical Capital offerings, selling $700 million of the product. About half of that amount is in default.

Latest News

LPL building out alts, banking services to chase wirehouse advisors, new CEO says
LPL building out alts, banking services to chase wirehouse advisors, new CEO says

New chief executive Rich Steinmeier replaced Dan Arnold on October 1.

Franklin Templeton CEO vows to "do what's right" amid record outflows
Franklin Templeton CEO vows to "do what's right" amid record outflows

The global firm is navigating a crisis of confidence as an SEC and DOJ probe into its Western Asset Management business sparked a historic $37B exodus.

For asset managers, easy experience is key to winning advisors' businesses
For asset managers, easy experience is key to winning advisors' businesses

Beyond returns, asset managers have to elevate their relationship with digital applications and a multichannel strategy, says JD Power.

Why retaining HNW clients ultimately comes down to one basic thing
Why retaining HNW clients ultimately comes down to one basic thing

New survey finds varied levels of loyalty to advisors by generation.

Stocks drop as investors digest Microsoft, Meta earnings
Stocks drop as investors digest Microsoft, Meta earnings

Busy day for results, key data give markets concerns.

SPONSORED Out with the old and in with the new: a 50% private markets portfolio

A great man died recently, but this did not make headlines. In fact, it barely even made the news. Maybe it’s because many have already mourned the departure of his greatest legacy: the 60/40 portfolio.

SPONSORED Destiny Wealth Partners: RIA Team of the Year shares keys to success

Discover the award-winning strategies behind Destiny Wealth Partners' client-centric approach.